ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 185 filers reported holding ARIAD PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,567,000 | -2.7% | 206,352 | +7.1% | 0.01% | 0.0% |
| Q3 2016 | $2,639,000 | +89.4% | 192,738 | +2.2% | 0.01% | +75.0% |
| Q2 2016 | $1,393,000 | +25.4% | 188,563 | +8.4% | 0.00% | +33.3% |
| Q1 2016 | $1,111,000 | +2.0% | 173,888 | -0.2% | 0.00% | -25.0% |
| Q4 2015 | $1,089,000 | +15.4% | 174,193 | +7.8% | 0.00% | +33.3% |
| Q3 2015 | $944,000 | -28.0% | 161,633 | +1.9% | 0.00% | -25.0% |
| Q2 2015 | $1,312,000 | -2.5% | 158,638 | -2.8% | 0.00% | 0.0% |
| Q1 2015 | $1,345,000 | +42.8% | 163,263 | +19.0% | 0.00% | +33.3% |
| Q4 2014 | $942,000 | +22.5% | 137,188 | -3.7% | 0.00% | +50.0% |
| Q3 2014 | $769,000 | -14.9% | 142,406 | +0.3% | 0.00% | -33.3% |
| Q2 2014 | $904,000 | -21.9% | 141,986 | -1.1% | 0.00% | 0.0% |
| Q1 2014 | $1,157,000 | +12.5% | 143,512 | -4.8% | 0.00% | 0.0% |
| Q4 2013 | $1,028,000 | -66.7% | 150,749 | -10.1% | 0.00% | -70.0% |
| Q3 2013 | $3,084,000 | +2.9% | 167,622 | -2.2% | 0.01% | 0.0% |
| Q2 2013 | $2,997,000 | – | 171,370 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $69,390,000 | 26.80% |
| Opaleye Management Inc. | 1,500,000 | $8,100,000,000 | 6.31% |
| Camber Capital Management LP | 6,000,000 | $32,400,000 | 3.04% |
| Ghost Tree Capital, LLC | 700,000 | $3,780,000 | 2.05% |
| Granite Point Capital Management, L.P. | 700,000 | $3,780,000 | 1.88% |
| Duquesne Family Office | 1,645,000 | $8,883,000 | 1.09% |
| Geduld E E | 272,200 | $1,470,000 | 1.04% |
| Elk Creek Partners, LLC | 659,232 | $3,560,000 | 0.93% |
| Palo Alto Investors LP | 2,231,717 | $12,051,000 | 0.90% |
| HighVista Strategies LLC | 1,200,000 | $6,480,000 | 0.87% |